基于神经同步化水平的闭环脑深部电刺激治疗帕金森病安全性及有效性探索研究

注册号:

Registration number:

ChiCTR2400085749 

最近更新日期:

Date of Last Refreshed on:

2024-06-18 10:32:23 

注册时间:

Date of Registration:

2024-06-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于神经同步化水平的闭环脑深部电刺激治疗帕金森病安全性及有效性探索研究

Public title:

Exploratory Study on the Safety and Efficacy of Closed-Loop Deep Brain Stimulation for Parkinson's Disease Based on the Level of Neural Synchronization

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于神经同步化水平的闭环脑深部电刺激治疗帕金森病安全性及有效性探索研究

Scientific title:

Exploratory Study on the Safety and Efficacy of Closed-Loop Deep Brain Stimulation for Parkinson's Disease Based on the Level of Neural Synchronization

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张新 

研究负责人:

陈亮 

Applicant:

Xin Zhang 

Study leader:

Liang Chen 

申请注册联系人电话:

Applicant telephone:

+86 13761626836

研究负责人电话:

Study leader's
telephone:

+86 21 65642662

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xinzhanghs@126.com

研究负责人电子邮件:

Study leader's E-mail:

chenlianghs@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市静安区乌鲁木齐中路12号

研究负责人通讯地址:

乌鲁木齐中路12号

Applicant address:

12 Middle Wulumuqi Road

Study leader's address:

No.12 Middle Wulumuqi Road,Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

复旦大学附属华山医院神经外科

Applicant's institution:

Department of Neurosurgery, Huashan Hospital, Fudan University

研究负责人所在单位:

复旦大学附属华山医院

Affiliation of the Leader:

Huashan Hospital, Fudan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2024)临审第(026)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

复旦大学附属华山医院伦理审查委员会

Name of the ethic committee:

Institutional Review Board Huashan Hospital Fudan University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-03-28 00:00:00

伦理委员会联系人:

全菁

Contact Name of the ethic committee:

Quan Jing

伦理委员会联系地址:

乌鲁木齐中路12号

Contact Address of the ethic committee:

No.12 Middle Wulumuqi Road,Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 52888921

伦理委员会联系人邮箱:

Contact email of the ethic committee:

quanjing1975@163.com

研究实施负责(组长)单位:

复旦大学附属华山医院

Primary sponsor:

Huashan Hospital, Fudan University

研究实施负责(组长)单位地址:

乌鲁木齐中路12号

Primary sponsor's address:

No.12 Middle Wulumuqi Road,Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属华山医院

具体地址:

乌鲁木齐中路12号

Institution
hospital:

Huashan Hospital, Fudan University

Address:

No.12 Middle Wulumuqi Road,Shanghai

经费或物资来源:

诊疗装备与生物医用材料;国家自然科学基金

Source(s) of funding:

National Key Research and Development Program of China(No. 2022YFC2405100);National Natural Science Foundation of China (No. 82201400)

研究疾病:

原发性帕金森病  

Target disease:

Parkinson's disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究对基于神经同步化水平的闭环DBS治疗帕金森病进行探索性研究。本研究将在帕金森病DBS手术中进行短时闭环DBS治疗测试,通过与常规电刺激比较,对其效果进行探索性研究。  

Objectives of Study:

This study conducts an exploratory investigation into closed-loop DBS treatment for Parkinson's disease based on neural synchronization levels. Short-term closed-loop DBS treatment tests will be conducted during Parkinson's disease DBS surgeries. An exploratory comparison of its effects will be made against conventional stimulation.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.MMSE低于24;
2.抑郁症(根据中国诊断标准)或严重精神疾病;
3.曾有明确脑部疾病史(明确卒中史、脑外伤史、脑部肿瘤史、脑积水);
4.合并严重的心脏、肝脏、肾脏等内科疾病者;
5.术前评估认为其不适于进行DBS手术者;
6.研究者认为其不适合参与本研究的其他情况;

Exclusion criteria:

1.MMSE score is lower than 24;
2.Depression (according to Chinese diagnostic criteria) or severe mental illness.
3.There is a history of definite brain diseases (such as stroke, head injury, brain tumor, or hydrocephalus).
4.Patients with severe internal medical conditions such as heart, liver, or kidney diseases are included.
5.Patients deemed unsuitable for DBS surgery based on preoperative assessment.
6.Other situations where researchers consider the participant unsuitable for inclusion in this study.

研究实施时间:

Study execute time:

From 2024-06-24 00:00:00 To 2026-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-24 00:00:00 To 2026-03-31 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

8

Group:

Study group

Sample size:

干预措施:

双侧闭环电刺激测试

干预措施代码:

Intervention:

bilateral closed-loop stimulation test

Intervention code:

组别:

对照组

样本量:

8

Group:

Control group

Sample size:

干预措施:

常规电刺激测试

干预措施代码:

Intervention:

Routine stimulation test

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属华山医院 

单位级别:

三级甲等 

Institution
hospital:

Huashan Hospital, Fudan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后一月开机时局部场电位

指标类型:

次要指标

Outcome:

LFP 1 month after the surgery

Type:

Secondary indicator

测量时间点:

术后一月开机时

测量方法:

采集脑电

Measure time point of outcome:

1 month after the surgery

Measure method:

Collect the LFP

指标中文名:

术中UPDRS量表评分

指标类型:

主要指标

Outcome:

Intraoperative UPDRS-III score

Type:

Primary indicator

测量时间点:

术中

测量方法:

量表评估

Measure time point of outcome:

during the operation

Measure method:

UPDRS

指标中文名:

术中局部场电位数据

指标类型:

次要指标

Outcome:

intraoperative LFP

Type:

Secondary indicator

测量时间点:

术中

测量方法:

采集脑电

Measure time point of outcome:

During the surgery

Measure method:

Collect the LFP

指标中文名:

术后一月UPDRS量表评分

指标类型:

次要指标

Outcome:

UPDRS-III score 1 month after the surgery

Type:

Secondary indicator

测量时间点:

术后一月开机时

测量方法:

UPDRS量表评估

Measure time point of outcome:

1 month after the surgery

Measure method:

UPDRS

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 55 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

软件生成

Randomization Procedure (please state who generates the random number sequence and by what method):

Software generation

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲

Blinding:

Single blind study

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

暂不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not available

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF & EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF & EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-06-18 10:31:59